You just read:

Genomic Health Announces Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of Oncotype DX® Genomic Prostate Score™ in Patients with Favorable Intermediate-risk Prostate Cancer

News provided by

Genomic Health, Inc.

May 04, 2017, 16:05 ET